Literature DB >> 900246

Effects of topical anesthetics on phenylephrine-induced mydriasis.

W M Lyle, W R Bobier.   

Abstract

Pupil responses to phenylephrine alone and to phenylephrine preceded by a topical anesthetic were recorded by means of an infrared pupillometer. In response to phenylephrine, pupils dilated more in eyes with pale irides. Dilation was greater if a topical anesthetic was applied before the mydriatic. Benoxinate, proparacaine, and tetracaine produced approximately equal degrees of enhancement of the mydriasis. One drop of 1% phenylephrine had only a small dilating effect on an eye when the fellow eye received the phenylephrine preceded by 0.5% proparacaine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900246     DOI: 10.1097/00006324-197705000-00002

Source DB:  PubMed          Journal:  Am J Optom Physiol Opt        ISSN: 0093-7002


  4 in total

1.  Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.

Authors:  Matt H Oltmanns; Sandeep S Samudre; Ivan G Castillo; Alireza Hosseini; Aron H Lichtman; Robert C Allen; Frank A Lattanzio; Patricia B Williams
Journal:  J Ocul Pharmacol Ther       Date:  2008-02       Impact factor: 2.671

2.  Comparison of two drug combinations for dilating dark irides.

Authors:  Heather A Anderson; Kimberly C Bertrand; Ruth E Manny; Ying-Sheng Hu; Karen D Fern
Journal:  Optom Vis Sci       Date:  2010-02       Impact factor: 1.973

3.  Randomised controlled single-blind study of conventional versus depot mydriatic drug delivery prior to cataract surgery.

Authors:  Vincent Dubois; Nadia Wittles; Meon Lamont; Simon Madge; Jon Luck
Journal:  BMC Ophthalmol       Date:  2006-11-27       Impact factor: 2.209

4.  Evaluating the potentiating effect of amethocaine on tropicamide-induced mydriasis in darkly pigmented irides, using infrared pupillometry.

Authors:  Olufunmilola A Ogun; Jeffrey W Oliver; Adeyinka O Ashaye; Benedictus Gk Ajayi
Journal:  Ophthalmol Eye Dis       Date:  2014-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.